David Thomson
Vermogen: 3 M $ op 31-05-2026
Vermogen: 3 M $ op 31-05-2026
David B. Thomson currently holds the positions of Secretary & Director at scPharmaceuticals, Inc. since 2025, Secretary, Executive VP & General Counsel at MannKind Corp.
since 2002, and Vice President at QrumPharma, Inc. Education history includes an undergraduate degree (1990), a graduate degree (1991), and a doctorate (1994) from Queen's University, as well as a graduate degree from the University of Toronto in 1999.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MANNKIND CORPORATION 0,27% | 12-05-2026 | 826.299 ( 0,27% ) | 3 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MANNKIND CORPORATION | Algemeen Adviseur | 01-01-2002 |
| SCPHARMACEUTICALS INC. | Directeur/Bestuurslid | 07-10-2025 |
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
MannKind Corp.
MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
scPharmaceuticals, Inc.
scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau